Choose your preferred way to stay informed of new case launches and settlement deadlines
The Wall Street Journal released a shocking report on April 12, 2024, detailing the alarming number of adverse events associated with the animal osteoarthritis pain medications Librela and Solensia, manufactured by Zoetis. Following this news, Zoetis's stock value dropped over 4%.
In order to be eligible to join the ZTS class action lawsuit, you must have incurred a loss on shares of Zoetis Inc. purchased during the class period listed above.
TOP
